Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Proteomics International Seeks Up to $5 Million in Discounted Share Plan

PIQ: $0.091 -24.17% · MC: $16M

Proteomics International Laboratories is seeking up to $5 million before costs through a share purchase plan, equivalent to about a quarter of its recent market capitalisation. The offer price is $0.10 per share, a discount of approximately 17% to the previous closing price, with a free option for each share subject to shareholder approval. The proposed funding is intended to support commercialisation, clinical and reimbursement work, product launches and US market preparations. The company recently began the national rollout of its Promarker D and Promarker Eso tests through Healius.

Source announcements: 2026-11-02 09:12 to 2026-11-02 09:31 Sydney time
Story updated 2026-11-02 10:26 Sydney time
SourcesProteomics International Launches Share Purchase PlanProposed issue of securities - PIQ
Comments